BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8524262)

  • 1. Regulation of p53-mediated apoptosis and cell cycle arrest by Steel factor.
    Abrahamson JL; Lee JM; Bernstein A
    Mol Cell Biol; 1995 Dec; 15(12):6953-60. PubMed ID: 8524262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-mediated cell cycle arrest and apoptosis.
    Lin Y; Benchimol S
    Leukemia; 1997 Apr; 11 Suppl 3():324-6. PubMed ID: 9209379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
    EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53.
    Kelley LL; Green WF; Hicks GG; Bondurant MC; Koury MJ; Ruley HE
    Mol Cell Biol; 1994 Jun; 14(6):4183-92. PubMed ID: 8196656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines inhibit p53-mediated apoptosis but not p53-mediated G1 arrest.
    Lin Y; Benchimol S
    Mol Cell Biol; 1995 Nov; 15(11):6045-54. PubMed ID: 7565757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin.
    Johnson P; Chung S; Benchimol S
    Mol Cell Biol; 1993 Mar; 13(3):1456-63. PubMed ID: 8441390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
    Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the molecular mechanisms for p53-mediated differentiation.
    Chylicki K; Ehinger M; Svedberg H; Gullberg U
    Cell Growth Differ; 2000 Nov; 11(11):561-71. PubMed ID: 11095245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells.
    Ryan JJ; Danish R; Gottlieb CA; Clarke MF
    Mol Cell Biol; 1993 Jan; 13(1):711-9. PubMed ID: 8417361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
    Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
    Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in p53 synthesis during differentiation of Friend-erythroleukemia cells. Correlation with the commitment to terminal cell division.
    Ben-Dori R; Resnitzki D; Kimchi A
    FEBS Lett; 1983 Oct; 162(2):384-9. PubMed ID: 6354748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 associates with trk tyrosine kinase.
    Montano X
    Oncogene; 1997 Jul; 15(3):245-56. PubMed ID: 9233759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.
    Wagner AJ; Kokontis JM; Hay N
    Genes Dev; 1994 Dec; 8(23):2817-30. PubMed ID: 7995520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53-mediated cell death: relationship to cell cycle control.
    Yonish-Rouach E; Grunwald D; Wilder S; Kimchi A; May E; Lawrence JJ; May P; Oren M
    Mol Cell Biol; 1993 Mar; 13(3):1415-23. PubMed ID: 8441387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A benzo[a]pyrene-induced cell cycle checkpoint resulting in p53-independent G1 arrest in 3T3 fibroblasts.
    Vaziri C; Faller DV
    J Biol Chem; 1997 Jan; 272(5):2762-9. PubMed ID: 9006915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
    Pohl U; Wagenknecht B; Naumann U; Weller M
    Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of p53 conformation and induction of apoptosis in a murine erythroleukemia cell line by dimethylsulfoxide.
    Ryan JJ; Clarke MF
    Leuk Res; 1994 Aug; 18(8):617-21. PubMed ID: 8065163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel p53 functional domain that is necessary for efficient growth suppression.
    Walker KK; Levine AJ
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15335-40. PubMed ID: 8986812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.
    Howard J; Ung Y; Adachi D; Ben-David Y
    Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein.
    Sabbatini P; Chiou SK; Rao L; White E
    Mol Cell Biol; 1995 Feb; 15(2):1060-70. PubMed ID: 7823921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.